Squamous metaplasia of lactiferous ducts (SMOLD): an under-recognised entity.

Breast abscesses are a common surgical problem, typically occurring secondary to lactation mastitis. Recurrent subareolar abscesses are rarely reported and may be poorly recognised as a presentation of squamous metaplasia of lactiferous ducts, known eponymously as 'Zuska's disease'. Other synonyms include subareolar breast abscess and lactiferous or mammary fistulas. Recognition of this painful entity is crucial for optimal outcomes since typical breast abscess management of recurrent aspiration or incision and drainage can lead to recurrence and chronic complications, such as fistula formation.

Optimizing biomechanical performance of the 4-strand cruciate flexor tendon repair.

PURPOSE: The purpose of this study was to determine whether increasing the size of the locking loop increased the repair strength of the cruciate 4-strand suture technique and to quantify the biomechanical properties that various peripheral suture techniques provide in the cruciate 4-strand suture technique. METHODS: Fifty-six deep flexor tendons harvested from adult sheep hind limbs were divided randomly into 7 groups of 8. Four groups were repaired using the cruciate core technique without a peripheral suture. The locking loops were set using 10%, 25%, 33%, or 50% of the tendon width and loaded to failure using a distraction rate of 20 mm/min. The 3 groups of tendons then were repaired by using the established optimal locking loop size. These 3 groups were combined with a simple running, cross-stitch, or the interlocking horizontal mattress (IHM) peripheral suture. Repairs were tested to failure and the load at a 2-mm gap, load at failure, and stiffness were determined for all samples. RESULTS: Repairs with locking loops of 25% had the greatest biomechanical properties with load to 2-mm gap formation, load to failure, and stiffness of 10 N, 46.3 N, and 3.9 N/mm, respectively. Those with 33%, 50%, and 10% locking loops followed. Repairs with 10% locking loops failed owing to the suture cut out of the tendon. All other groups failed because of suture breakage. By using the cruciate core technique with a 25% locking loop the IHM/cruciate combination was markedly better than both the cross-stitch/cruciate and simple running/cruciate combinations. CONCLUSIONS: The ideal-sized bite of the locking loops for the cruciate repair is 25% of the tendon's width. Peripheral sutures are vital to the biomechanical properties of the repair. The IHM peripheral suture technique provided the greatest improvement in biomechanical properties.

Biomechanical properties of four circumferential flexor tendon suture techniques.

PURPOSE: We introduce 2 interlocking circumferential flexor tendon suture techniques: the interlocking cross-stitch and the interlocking horizontal mattress repair and biomechanically tested them against 2 commonly used methods. METHODS: Thirty-two deep digital flexor tendons harvested from sheep hindlimbs were transected sharply. These were repaired without a core suture using 4 different circumferential repair techniques: group 1, simple running; group 2, cross-stitch; group 3, interlocking cross-stitch; group 4, interlocking horizontal mattress. All tendons were tested to failure at a distraction rate of 20 mm/min. Load to 2-mm gap formation, stiffness, load to failure, and method of failure all were assessed. RESULTS: The mean load to 2-mm gap formation was 22.8, 20.7, 20.0, and 26.1 N for groups 1, 2, 3, and 4, respectively. The mean stiffness was 7.6, 8.1, 8.7, and 10.1 N/mm, and the mean load to failure was 30.9, 42.1, 49, and 52.9 N for groups 1, 2, 3, and 4, respectively. There was no statistically significant difference between groups 2 and 3. Group 4, however, was statistically better than the others in all measured parameters (except group 3 in load to failure). CONCLUSIONS: The interlocking horizontal mattress was the best performer overall, with statistically greater loads to failure, 2-mm gap formation, and stiffness. This technique could be considered for use in any patient likely to begin an early postoperative finger mobilization program.

Metastatic cutaneous squamous cell carcinoma to the parotid: the role of surgery and adjuvant radiotherapy to achieve best outcome.

BACKGROUND: Australia has the highest incidence of cutaneous squamous cell carcinoma in the world. The majority of lesions occur in the head and neck with metastases to the parotid gland lymph nodes reflecting an uncommon, but aggressive, manifestation. Parotidectomy +/- neck dissection followed by adjuvant radiotherapy should be considered as best practice. METHODS: Between 1983 and 2000, seventy-four patients were treated for metastatic cutaneous squamous cell carcinoma to the parotid with surgery and adjuvant radiotherapy at Westmead Hospital, Sydney. Relevant data were extracted from patient files and a prospectively maintained database. Patterns of relapse and outcome were analysed. RESULTS: Median age at diagnosis was 65 years (34-93 years) in 63 men and 11 women. Median follow-up duration was 41 months (12-188 months). All patients underwent parotidectomy with 52 undergoing a simultaneous neck dissection. Twelve patients required sacrifice of the facial nerve (4) or one or more branches (8). All received adjuvant radiotherapy to the parotid region with 56 also receiving radiotherapy to the ipsilateral neck. Despite treatment, 24% developed locoregional recurrence, with a median time to relapse of 7.5 months. The most common site for recurrence was the treated parotid region and upper neck. Most relapsed patients died. No variable independently predicted for locoregional recurrence on multivariate analysis. The 5-year absolute and cause-specific survival rates were 58% and 72%, respectively. CONCLUSION: Parotid gland lymph node metastases from cutaneous squamous cell carcinoma are associated with a high rate of recurrence and cause-specific mortality despite current best practice (surgery and high dose adjuvant radiotherapy). The role of more aggressive surgery, altered fractionation or chemotherapy to enhance locoregional control remains unclear.